Technical Analysis for DVAX - Dynavax Technologies Corporation

Grade Last Price % Change Price Change
grade D 17.75 -4.57% -0.85
DVAX closed down 4.57 percent on Tuesday, December 12, 2017, on approximately normal volume.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical DVAX trend table...

Date Alert Name Type % Chg
Dec 12 Bearish Engulfing Bearish 0.00%
Dec 12 Evening Star Bearish 0.00%
Dec 12 Bollinger Band Squeeze Range Contraction 0.00%
Dec 12 Wide Bands Range Expansion 0.00%
Dec 11 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.57%
Dec 11 MACD Bullish Signal Line Cross Bullish -4.57%
Dec 11 Bollinger Band Squeeze Range Contraction -4.57%
Dec 11 Wide Bands Range Expansion -4.57%
Dec 11 Up 3 Days in a Row Strength -4.57%
Dec 8 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.01%

Older signals for DVAX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. It develops product candidates based on the use of immunostimulatory sequences and immunoregulatory sequences. Its lead product candidate is HEPLISAV, a Phase III investigational adult hepatitis B vaccine. The company also develops DV1179, a Phase I bifunctional inhibitor of TLR7 and TLR9 for the treatment of autoimmune and inflammatory diseases; and AZD1419, a preclinical drug candidate for the treatment of asthma. It has a strategic alliance with GlaxoSmithKline to discover, develop, and commercialize TLR inhibitors; and a research collaboration and license agreement with AstraZeneca AB for the discovery and development of TLR9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is based in Berkeley, California.
Is DVAX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 24.45
52 Week Low 3.7
Average Volume 1,756,903
200-Day Moving Average 12.8784
50-Day Moving Average 20.3084
20-Day Moving Average 18.3195
10-Day Moving Average 18.265
Average True Range 1.0847
ADX 18.82
+DI 19.68
-DI 25.02
Chandelier Exit (Long, 3 ATRs ) 18.9959
Chandelier Exit (Short, 3 ATRs ) 20.1041
Upper Bollinger Band 19.704
Lower Bollinger Band 16.935
Percent B (%b) 0.29
BandWidth 15.115041
MACD Line -0.5895
MACD Signal Line -0.6206
MACD Histogram 0.0311
Fundamentals Value
Market Cap 973.39 Million
Num Shares 54.8 Million
EPS -2.42
Price-to-Earnings (P/E) Ratio -7.33
Price-to-Sales 143.85
Price-to-Book 7.89
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.28
Resistance 3 (R3) 19.42 19.04 19.03
Resistance 2 (R2) 19.04 18.65 18.98 18.94
Resistance 1 (R1) 18.40 18.41 18.21 18.26 18.85
Pivot Point 18.02 18.02 17.93 17.96 18.02
Support 1 (S1) 17.38 17.63 17.19 17.24 16.65
Support 2 (S2) 17.00 17.39 16.94 16.56
Support 3 (S3) 16.36 17.00 16.48
Support 4 (S4) 16.22